PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit
- Products
-
- DULoxetine DR USP
- Company
- PD-Rx Pharmaceuticals, Inc.
- Where it was sold
-
Distributed within US: FL, MS, WI
States: Florida, Mississippi, Wisconsin
- Units affected
- 70, 90-count bottles
- About this recall
- DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90